Comment on

• Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

  Jachiet V, Kosmider O, Beydon M, Hadjadj J, Zhao LP, Grobost V, Lacombe V, Le Guenno G, Nguyen Y, Arlet JB, Dion J, Heiblig M, Garnier A, Samson M, Aouba A, Thépot S, Dimicoli-Salazar S, Dutasta F, Faucher B, Lazaro E, Morel V, Néel A, Outh R, Bezanahary H, Rossignol J, Alary AS, Bidet A, Blateau P, Bouvier A, Boursier G, Decamp M, Lebecque B, Le Bris Y, Sujobert P, Marceau-Renaut A, Pastoret C, Rizzo D, Boiret-Dupré N, Boucher L, Dulucq S, Genevieve F, Jadeau C, Lemaire P, Vazquez R, Rieu JB, Fain O, Georgin-Lavialle S, Rigolot L, Larcher L, Hirsch P, Terrier B, Fenaux P, Mékinian A, Comont T. Jachiet V, et al. Blood. 2025 Sep 18;146(12):1450-1461. doi: 10.1182/blood.2024028133. Blood. 2025. PMID: 40373272